Allows prediction, for breast cancer patients, of survival, response to hormonal treatment and response to targeted therapy. Recurrence Online is a classification system capable of using common genome-wide microarrays to assess hormone receptor status and to compute the risk of recurrence. RS calculator computes ER status, HER2 status and survival, and the Re-training algorithm predicts the risk of relapse. The software performs all bioinformatic steps automatically and is therefore suitable for users with negligible statistical knowledge.
Laboratory of Functional Genomics, Charité, Berlin, Germany; Research Laboratory for Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Pázmány Péter Catholic University, Faculty of Informatic Technology, Budapest, Hungary; Children’s Hospital Informatics Program, Harvard Medical School, Boston, MA USA; 2nd Department of Pathology, Semmelweis University, Budapest, Hungary